This protocol is judged by an institutional critique board, an impartial group that testimonials any medical trials involving humans. If a review will involve a Program I drug, after the board approves the protocol as moral, the researchers really need to make an application for an investigational new drug (IND) amount from your FDA.Weiser urged so